Cargando…
Benefit‐Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments
Autores principales: | Florian, Jeffry, Zhuang, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702898/ http://dx.doi.org/10.1002/psp4.12216 |
Ejemplares similares
-
Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature
por: Kürzinger, Marie-Laure, et al.
Publicado: (2020) -
Residual Isocyanates in Medical Devices and Products: A Qualitative and Quantitative Assessment
por: Franklin, Gillian, et al.
Publicado: (2016) -
The value of quantitative patient preferences in regulatory benefit-risk assessment
por: Egbrink, Mart oude, et al.
Publicado: (2014) -
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
por: Caster, Ola, et al.
Publicado: (2015) -
Quantitative Benefit–Risk Assessment: State of the Practice Within Industry
por: Smith, Meredith Y., et al.
Publicado: (2020)